STRIDES PHARMA SCIENCE
Back to Balance Sheet
|
STRIDES PHARMA SCIENCE Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹119 Cr | ₹98 Cr | ₹475 Cr | ₹632 Cr | ₹834 Cr |
What is the latest Contingent Liabilities ratio of STRIDES PHARMA SCIENCE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹119 Cr |
| Mar2025 | ₹98 Cr |
| Mar2024 | ₹475 Cr |
| Mar2023 | ₹632 Cr |
| Mar2022 | ₹834 Cr |
How is Contingent Liabilities of STRIDES PHARMA SCIENCE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹119 Cr | 20.82 | |
| Mar2025 | ₹98 Cr | -79.34 | |
| Mar2024 | ₹475 Cr | -24.88 | |
| Mar2023 | ₹632 Cr | -24.25 | |
| Mar2022 | ₹834 Cr | - | |
Compare Contingent Liabilities of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹9,758.0 Cr | 3.3% | 6.3% | 17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | 3.3% |
6.3% |
17.4% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses